Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Rene A Oliveros"'
Publikováno v:
Diabetes, Obesity and Metabolism. 21:451-453
Publikováno v:
Current Diabetes Reports. 18
To evaluate the treatment of type 2 diabetes from a cardiologist’s view. A new era in the treatment of type 2 diabetes began for the cardiologist in 2015 with the publication of the EMPA-REG outcome trial finding a significant reduction in CV death
Autor:
Robert J. Chilton, Joan Hecht, Joaquin E. Cigarroa, Benjamin Garza, Christopher Baez, Rene A Oliveros, Michael Balderas
Publikováno v:
Hypertension. 70
The aim of this study was to see if there is any association between masked hypertension (MHTN) and orthostatic HTN (OHTN). In addition, we evaluated if MHTN was associated with diabetes (DM). Lastly we compared BP and HR changes between DM and non-d
Autor:
Rushit Kanakia, Faris G. Araj, Rene A Oliveros, Hu Yu, Saurabh Sanon, Robert J. Chilton, Vani P. Sanon
Publikováno v:
Clinical Cardiology. 37:499-504
Hypoglycemia in people with diabetes mellitus (DM) has been potentially linked to cardiovascular morbidity and mortality. Pathophysiologically, hypoglycemia triggers activation of the sympathoadrenal system, leading to an increase in counter-regulato
Publikováno v:
Journal of the American College of Cardiology. 73:1789
Red blood cell distribution width (RDW) is an automated measure of red blood cell size. It is considered a novel biomarker, independently associated with morbidity and mortality in cardiovascular disease (CVD). RDW is elevated in prehypertensive and
Autor:
Rikesh Patel, Carrie Eshelbrenner, Son V. Pham, Vani P. Sanon, Robert J. Chilton, Saurabh Sanon, Rene A Oliveros, Mohsin Alhaddad
Publikováno v:
The American Journal of Cardiology. 110:13B-23B
Diabetes mellitus (DM) is well known to be a coronary artery disease risk equivalent but the cellular mechanism is not completely understood. Recently, virtual histology intravascular ultrasound has demonstrated that patients with DM tend to have a h
Publikováno v:
Spring. 9:26-29
Evidence-based medicine is key to the cardiologist’s role in the management of type 2 diabetes. Proven therapies that reduce cardiovascular (cV) events with few off-target effects are imperative. evidence from epidemiology studies supports the conc
Publikováno v:
The American Journal of Medicine. 124:S35-S53
The global epidemic of diabetes mellitus (~95% type 2 diabetes) has been fueled by a parallel increase in obesity and overweight. Together, these metabolic disease epidemics have contributed to the increasing incidence and prevalence of cardiovascula
Autor:
Melanie S. Sulistio, Mike Lujan, Curtis Carothers, Rene A Oliveros, Mandeep Mangat, Robert J. Chilton
Publikováno v:
Current Atherosclerosis Reports. 11:93-99
Cardiovascular disease is a leading cause of death in the United States and across the world, and better therapies are constantly being sought to improve patient outcomes. Recent studies have brought our attention to the mechanisms of glucagon-like p
Autor:
Sik Hur, Rikesh Patel, Suraj Maraj, Robert J. Chilton, Tim Dao, Saurabh Sanon, Rene A Oliveros
Publikováno v:
Journal of Diabetes & Metabolism.
Treatment of hypertension using renal artery sympathetic denervation was first reported as early as 1924, but only recently has the advent of safer, less invasive techniques allowed this treatment modality to emerge as a promising treatment for hyper